Clinical Trials
3 trialsNCT06997068 2026-05-11
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Mayo Clinic
Phase 2 Recruiting
NCT06662058 2026-04-23
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Emory University
Phase NA Recruiting
NCT01148082 2017-06-26
School Response to Families Who Have Children With Cancer
Stanford University
Withdrawn